Review of the use of botulinum toxin for hyperhidrosis and cosmetic purposes

Clinical Journal of Pain

Volumn 18, Issue 6 SUPPL., 2002, Pages

  Glogau, Richard G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Botox; Botulinum toxins; Cosmetic; Hyperhidrosis; Myobloc

Indexed keywords

BOTULINUM TOXIN A; BOTULINUM TOXIN B;

DOSE RESPONSE; DRUG DIFFUSION; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG EFFICACY; DRUG INDICATION; DRUG INDUCED DISEASE; DRUG RESPONSE; DRUG USE; DYSPHAGIA; DYSTONIA; ECCHYMOSIS; EXPERIENCE; FACE ASYMMETRY; FOREHEAD; HUMAN; HYPERHIDROSIS; INJECTION PAIN; MUSCLE WEAKNESS; PLATYSMA MUSCLE; PRIORITY JOURNAL; PTOSIS; REVIEW; SKIN DEFECT; STAMEN; TREATMENT INDICATION;

BOTULINUM TOXIN TYPE A; BOTULINUM TOXINS; COSMETIC TECHNIQUES; COSMETICS; DERMATOLOGY; DOSE-RESPONSE RELATIONSHIP, DRUG; FACE; FACIAL MUSCLES; HUMANS; HYPERHIDROSIS; INJECTIONS, INTRAMUSCULAR; INJECTIONS, SUBCUTANEOUS; SKIN AGING; TREATMENT OUTCOME;

EID: 0036840945     PISSN: 07498047     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002508-200211001-00012     Document Type: Review

References (36)

1. Schantz EJ. Historical perspective. In: Jankovic J, Hallett M, eds. Therapy with Botulinum Toxin. New York: Marcel Dekker: 1994:xxiii-xxvi.
2. Burke GS. Notes on Bacillus botulinus. J Bacteriol 1919;4:555-65. Cited by: Carruthers A, Carruthers J. Botulinum toxin type A: history and current cosmetic use in the upper face. Semin Cutan Med Surg 2001;20:71-84.
3. Burke GS. Notes on Bacillus botulinus. J Bacteriol 1919;4:555-65. Cited by: Carruthers A, Carruthers J. Botulinum toxin type A: History and current cosmetic use in the upper face. Semin Cutan Med Surg 2001;20:71-84.
4. Schantz EJ, Johnson EA. Botulinum toxin: The story of its development for the treatment of human disease. Perspect Biol Med 1997;40:317-27.
5. Scott AB. Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery. Ophthalmology 1980;87:1044-9.
6. Jost WH, Kohl A. Botulinum toxin: Evidence-based medicine criteria in rare indications. J Neurol 2001;248(suppl 1):39-44.
7. Schantz EJ, Johnson EA. Preparation and characterization of botulinum toxin type A for human treatment. In: Jankovic J, Hallett M, eds. Therapy with Botulinum Toxin. New York: Marcel Dekker; 1994:15-39.
8. Pearce LB, Borodic GE, Johnson EA, et al. The median paralysis unit: A more pharmacologically relevant unit of biologic activity for botulinum toxin. Toxicon 1995;33:217-27.
9. Data on file, Elan.
10. Callaway JE, Arezzo JC, Grethlein AJ. Botulinum toxin type B: An overview of its biochemistry and preclinical pharmacology. Semin Cutan Med Surg 2001;20:127-36.
11. Shaari CM, Sanders I. Quantifying how location and dose of botulinum toxin injections affect muscle paralysis. Muscle Nerve 1993; 16:964-9.
12. Borodic GE, Ferrante R, Pearce LB, et al. Histologic assessment of dose-related diffusion and muscle fiber response after therapeutic botulinum A toxin injections. Mov Disord 1994;9:31-9.
13. Fagien S, Brandt FS. Primary and adjunctive use of botulinum toxin type A (Botox) in facial aesthetic surgery: Beyond the glabella. Clin Plast Surg 2001;28:127-48.
14. Carruthers A, Carruthers J. Botulinum toxin type A: History and current cosmetic use in the upper face. Semin Cutan Med Surg 2001;20:71-84.
15. Borodic GE. Botulinum A toxin for (expressionistic) ptosis overcorrection after frontalis sling. Ophthal Plast Reconstruct Surg 1992;8:137-42.
16. Carruthers JDA, Carruthers JA. Treatment of glabellar frown lines with C botulinum-A exotoxin. J Dermatol Surg Oncol 1992;18:17-21.
17. Carruthers J, Carruthers A. Botox use in the mid and lower face and neck. Semin Cutan Med Surg 2001:20:85-92.
18. Klein AW. Complications and adverse reactions with the use of botulinum toxin. Sem Cutan Med Surg 2001;20:109-20.
19. Markey AC, Glogau RG. Botulinum A exotoxin in dermatology: A synopsis. Presented at: American Osteopathic College of Dermatology Annual Meeting; October 27, 1999; San Francisco, CA.
20. Markey AC. Botulinum A exotoxin in cosmetic dermatology. Clin Exp Dermatol 2000;25:173-5.
21. Keen M, Blitzer A, Aviv J, et al. Botulinum toxin A for hyperkinetic facial lines: Results of a double-blind, placebo-controlled study. Plast Reconstruct Surg 1994;94:94-9.
22. Lowe NJ, Maxwell A, Harper H. Botulinum A exotoxin for glabellar folds: A double-blind, placebo-controlled study with an electromyographic injection technique. J Am Acad Dermatol 1996;35:569-72.
23. Brashear A, Lew MF, Dykstra DD, et al. Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia. Neurology 1999;53:1439-46.
24. Brin MF, Lew MF, Adler CH, et al. Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia. Neurology 1999;53:1431-38.
25. Bushara KO, Park DM. Botulinum toxin and sweating. J Neurol Neurosurg Psychiatry 1994;57:1437-8 [letter].
26. Naumann M. Evidence-based medicine: Botulinum toxin in focal hyperhidrosis. J Neurol 2001:248(suppl 1):31-3.
27. Naumann M, Flachenecker P, Bröcker E-B, et al. Botulinum toxin for palmar hyperhidrosis. Lancet 1997;349:252 (letter).
28. Naver H, Swartling C, Aquilonius SM. Treatment of focal hyperhidrosis with botulinum toxin type A: Brief overview of methodology and 2 years' experience. Eur J Neurol 1999;6:S117-20.
29. Glogau RG. Treatment of palmar hyperhidrosis with botulinum toxin. Semin Cutan Med Surg 2001;20:101-8.
30. Glogau RG. Botulinum A neurotoxin for axillary hyperhidrosis. No sweat Botox. Dermatol Surg 1998;24:817-9.
31. Heckmann M, Breit S, Ceballos-Baumann A, et al. Side-controlled intradermal injection of botulinum toxin A in recalcitrant axillary hyperhidrosis. J Am Acad Dermatol 1999;41:987-90.
32. Schnider P, Binder M, Kittler H, et al. Arandomized, double-blind, placebo-controlled trial of botulinum A toxin for severe axillary hyperhidrosis. Br J Dermatol 1999;140:677-80.
33. Drobik C, Laskawi R. Frey's syndrome: Treatment with botulinum toxin. Acta Otolaryngol 1995;115:459-61.
34. Laccourreye O, Akl E, Gutierrez-Fonseca R, et al. Recurrent gustatory sweating (Frey syndrome) after intracutaneous injection of botulinum toxin type A. Arch Otolaryngol Head Neck Surg 1999; 125:282-6.
35. Fujita M, Mann T, Mann O, et al. Surgical pearl: Use of nerve blocks for botulinum toxin treatment of palmar-plantar hyperhidrosis. J Am Acad Dermatol 2001;45:587-9.
36. de Almeida AR, Kadunc BV, de Olivera EM. Improving botulinum toxin therapy for palmar hyperhidrosis: Wrist block and technical considerations. Dermatol Surg 2001;27:34-6.